Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients
- 3 January 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 29 (12) , 1510-1515
Abstract
We examined the adequacy of endogenous erythropoietin (EPO) levels for the degree of anaemia in patients with chronic heart failure (CHF) and its relation to prognosis. We studied 74 anaemic CHF patients from a cohort of 240 patients. The adequacy of endogenous EPO levels was assessed by derived observed/predicted (O/P) ratio. A ratio value < 0.92 indicates EPO levels lower than expected, whereas a value > 1.09 indicates EPO levels higher than expected. The primary endpoint was mortality. During a median follow up of 4.9 years, 35 of the 74 (47.3%) anaemic patients died. EPO levels lower than expected were observed in 29 patients (39%), whereas EPO levels higher than expected were present in 22 anaemic patients (29%). The Kaplan-Meier analysis revealed that anaemic patients with EPO levels higher than expected had a significantly higher mortality rate compared to patients with EPO levels as expected or EPO levels lower than expected (log-rank: P = 0.024). A higher O/P ratio was an independent predictor of increased mortality risk adjusted for variables including age, sex, haemoglobin, NT-proBNP, and renal function; hazard ratio (HR): 1.020 95%CI (1.004-1.036), P = 0.012. EPO levels higher than expected, suggesting resistance to the hormone, are common in CHF patients and are associated with a higher mortality.Keywords
This publication has 25 references indexed in Scilit:
- Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer–Alkmaar heart failure studyHeart, 2006
- Drawbacks and Prognostic Value of Formulas Estimating Renal Function in Patients With Chronic Heart Failure and Systolic DysfunctionCirculation, 2006
- Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as wellEuropean Heart Journal, 2006
- Circulating Erythropoietin Levels and Prognosis in Patients With Congestive Heart FailureArchives of internal medicine (1960), 2005
- Prevalence of anemia and effects on mortality in patients with heart failureAmerican Heart Journal, 2005
- Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failureJACC, 2004
- Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trialEuropean Heart Journal, 2004
- Erythropoietin in cardiovascular diseasesEuropean Heart Journal, 2004
- Anemia Is Common in Heart Failure and Is Associated With Poor OutcomesCirculation, 2003
- Erratum Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001